Biomarker Research Initiatives Expanded to Include Clinical Research Applications
May 23 2007
Mass Spectrometry
Thermo Fisher Scientific Inc., the world leader in serving science, announces that its Biomarker Research Initiative in Mass Spectrometry (BRIMS) center has expanded its capabilities to involve clinical validation and clinical application assays. The center was initially established to focus on protein biomarker discovery, and subsequently developed an end-to-end mass spectrometry workflow including a complete sample preparation protocol as well as SIEVE(TM), a new software tool which automates label-free, semi-quantitative differential expression of proteins and peptides by comparing LC/MS analyses from large datasets.
Thermo Fisher Scientific originally partnered with Massachusetts General Hospital on BRIMS to focus on protein biomarker discovery. The large quantity of well-annotated plasma samples that were available at the hospital were ideally suited for research in biomarker discovery using the Thermo Scientific LTQ FT and LTQ Orbitrap. Moving into the next stage of biomarker verification, the center now uses the Thermo Scientific TSQ Quantum(TM) triple-quadrupole platform to develop targeted highly selective reaction monitoring (H-SRM) and multiple reaction monitoring assays for peptides and protein biomarker quantitation.
Mary Lopez, director of the BRIMS center comments, "The center's focus is shifting. Proteomics is evolving and as proteomics has gone from a science that was really more discovery based into a science that is becoming now more quantitative and has applications in the clinical world, we have also moved forward. The BRIMS center will continue to expand and establish collaborations with the leading scientists in biomarker research in cancer and cardiovascular disease, with the aim of developing clinical workflows and platforms".
Following the Thermo Fisher acquisition of Cohesive Technologies, BRIMS incorporates the novel Thermo Scientific TurboFlow(TM) technology system's novel approach to sample preparation and separation for MS. The TurboFlow technology minimizes sample preparation, especially for drug discovery, drug development and clinical research applications resulting in a unique LC-MS/MS solution when coupled with the TSQ Quantum triple quadrupole mass spectrometer and FAIMS (High-Field Asymmetric Ion Mobility Mass Spectrometry) technology.
The BRIMS center also utilizes Thermo Fisher protein/peptide sample enrichment products, as well as the SILAC Protein Quantitation Kits which, when used in conjunction with Thermo Scientific high resolution mass spectrometers, help facilitate MS analysis of low-abundance proteins.
For more information on the Thermo Scientific BRIMS center:
please call +1 800-532-4752
e-mail analyze@thermofisher.com
or
visit http://www.thermo.com/ms.
Thermo Fisher delivers MS innovation to every laboratory
About Thermo Fisher Scientific
Thermo Fisher Scientific Inc. (NYSE: TMO) is the world leader in serving science, enabling our customers to make the world healthier, cleaner and safer. With an annual revenue rate of more than $9 billion, we employ 30,000 people and serve over 350,000 customers within pharmaceutical and biotech companies, hospitals and clinical diagnostic labs, universities, research institutions and government agencies, as well as environmental and industrial process control settings. Serving customers through two premier brands, Thermo Scientific and Fisher Scientific, we help solve analytical challenges from routine testing to complex research and discovery. Thermo Scientific offers customers a complete range of high-end analytical instruments as well as laboratory equipment, software, services, consumables and reagents to enable integrated laboratory workflow solutions. Fisher Scientific provides a complete portfolio of laboratory equipment, chemicals, supplies and services used in healthcare, scientific research, safety and education. Together, we offer the most convenient purchasing options to customers and continuously advance our technologies to accelerate the pace of scientific discovery, enhance value for customers and fuel growth for shareholders and employees alike.
Visit www.thermofisher.com.
